Where Next For Sesen Bio’s Bladder Cancer Therapy Vicineum?

First-Mover Hopes Dashed By CRL

 
• By Sten Stovall
  
CRL came just days before priority review target PDUFA date of 18 August. • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapeutic Category